Alnylam Pharmaceuticals, Inc. (ALNY)

Healthcare · Biotechnology · NASDAQ

Nasdaq-100

Alnylam Pharmaceuticals, Inc. (ALNY) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $33.67B, a trailing price-to-earnings ratio of 31.5 and a free-cash-flow yield of 1.4%. Over the most recent reported fiscal year, revenue grew 65.2%.

Market cap	$33.67B
Trailing P/E	31.5
FCF yield	1.4%
Revenue growth (YoY)	+65.2%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live ALNY data on Nama Insights →

Recent Congressional trades

Alnylam Pharmaceuticals, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Cory A Booker	Senate	Sell	$1,001 - $15,000	Sep 9, 2026
Jefferson Shreve	House	Sell	$15,001 - $50,000	Jun 22, 2025
Josh Gottheimer	House	Sell	$1,001 - $15,000	Feb 15, 2024
Josh Gottheimer	House	Buy	$1,001 - $15,000	Feb 15, 2024
Josh Gottheimer	House	Sell	$1,001 - $15,000	Jan 7, 2024